HIV Stigma Mechanisms Scale: Factor Structure, Reliability, and Validity in Mexican Adults

被引:0
作者
Andrea López
Claudia Rafful
Ricardo Orozco
José Alfredo Contreras-Valdez
Leonardo Jiménez-Rivagorza
Missael Morales
机构
[1] Universidad Nacional Autónoma de México,Faculty of Psychology
[2] National Institute of Psychiatry,Center for Global Mental Health
来源
AIDS and Behavior | 2023年 / 27卷
关键词
stigma; HIV; validity; Mexican population;
D O I
暂无
中图分类号
学科分类号
摘要
We aimed to validate the HIV Stigma Mechanisms Scale (HIV-SMS) in a sample of Mexican adults living with HIV, which differentiates between sources and mechanisms of stigma. Adults (n = 362) with a median age of 32 years old completed a web-based version in Spanish of the HIV-SMS as well as sociodemographic and HIV-related characteristics questionnaire. Exploratory factor analyses with weighted least squares and oblique rotation were performed to assess the construct validity of the scale. The Spanish translation for the Mexican population of the HIV-SMS has adequate internal consistency (Ω = 0.86) and demonstrated a structure similar to the original scale. After excluding the items related to community and social workers, a five-factor solution with internalized, promulgated, and anticipated stigma from family and healthcare workers showed adequate construct validity. The HIV-SMS is a valid and sensitive scale that can be used in a Mexican adult population living with HIV.
引用
收藏
页码:1321 / 1328
页数:7
相关论文
共 99 条
[1]  
Florom-Smith AL(2012)Exploring the Concept of HIV-Related Stigma Nurs Forum 47 153-65
[2]  
De Santis JP(2009)From Conceptualizing to Measuring HIV Stigma: A Review of HIV Stigma Mechanism Measures AIDS Behav 13 1160-25
[3]  
Earnshaw VA(2006)Towards a sustainable theory of health-related stigma: lessons from the HIV/AIDS literature J Community Appl Social Psychol 16 418-610
[4]  
Chaudoir SR(2020)Combating HIV stigma in low- and middle-income healthcare settings: a scoping review J Int AIDS Soc 23 e25553-55
[5]  
Deacon H(2015)Effect of universal access to antiretroviral therapy on HIV/AIDS mortality in Mexico 1990 2011 JAIDS 69 e100-e8-12
[6]  
Smith MK(2016)CD4 Counts at Entry to HIV Care in Mexico for Patients under the “Universal Antiretroviral Treatment Program for the Uninsured Population,“ 2007–2014 PLoS ONE 11 e0152444-95
[7]  
Xu RH(2020)The stratified biomedicalization of HIV prevention in Mexico City Glob Public Health 15 598-69
[8]  
Hunt SL(2020)Perceived Need and Acceptability of a Community-Based Peer Navigator Model to Engage Key Populations in HIV Care in Tijuana, Mexico J Int Assoc Provid AIDS Care 19 2325958220919276-421
[9]  
Wei C(2008)Relationship between physicians and HIV patients: influence on adherence and quality of life Rev Saude Publica 42 249-47
[10]  
Tucker JD(2018)Evaluating the care cascade after antiretroviral therapy initiation in Latin America Int J STD AIDS 29 4-7